Live Attenuated Vaccines Market 2027 By Type, End User and Geography | The Insight Partners

Live Attenuated Vaccines Market to 2027 - Global Analysis and Forecasts by Type (Viral and Bacterial); End User (Hospitals, Clinics, Research Institutes, and Other End Users) and Geography

Report Code: TIPRE00004591 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Live attenuated vaccines are produced from the pathogens which are weakened at such a level that they can grow in vaccinated person but causes no or mild disease formation. These vaccines helps in creating the immune response which protects the vaccinated individual from acquiring the same disease. The WHO recommended vaccines such as BCG, polio vaccine, measles, rotavirus and yellow fever are made by attenuation.

MARKET DYNAMICS
The live attenuated vaccines market is expected to grow during the forecast period due to awareness regarding vaccination, hike in funding by government to and steps taken to make vaccination compulsory for children. Furthermore, the growing occurrence of infectious diseases are providing the opportunity to market.

MARKET SCOPE
The "Global Live Attenuated Vaccines Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of live attenuated vaccines market with detailed market segmentation by type, end user and geography. The global live attenuated vaccines market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading live attenuated vaccines market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global live attenuated vaccines market is segmented on the basis of type and end user. Based on type, the market is classified as viral and bacterial. On the basis of end user, the market is classified as hospitals, clinics, research institutes and other end users.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global live attenuated vaccines market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The live attenuated vaccines market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting live attenuated vaccines market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the live attenuated vaccines market in these regions.

MARKET PLAYERS
The reports cover key developments in the live attenuated vaccines market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from live attenuated vaccines market are anticipated to lucrative growth opportunities in the future with the rising demand for live attenuated vaccines market in the global market. Below mentioned is the list of few companies engaged in the live attenuated vaccines market.

The report also includes the profiles of key live attenuated vaccines market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline plc
  • BioDiem
  • AstraZeneca
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi
  • Serum institute of India Pvt. Ltd.
  • CSL Limited
  • Vivaldi Biosciences Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Live Attenuated Vaccines Market - By Type
1.3.2 Live Attenuated Vaccines Market - By End User
1.3.3 Live Attenuated Vaccines Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. LIVE ATTENUATED VACCINES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. LIVE ATTENUATED VACCINES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. LIVE ATTENUATED VACCINES MARKET - GLOBAL MARKET ANALYSIS
6.1. LIVE ATTENUATED VACCINES - GLOBAL MARKET OVERVIEW
6.2. LIVE ATTENUATED VACCINES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. LIVE ATTENUATED VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. VIRAL
7.3.1. Overview
7.3.2. Viral Market Forecast and Analysis
7.4. BACTERIAL
7.4.1. Overview
7.4.2. Bacterial Market Forecast and Analysis
8. LIVE ATTENUATED VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. RESEARCH INSTITUTES
8.5.1. Overview
8.5.2. Research Institutes Market Forecast and Analysis
8.6. OTHER END USERS
8.6.1. Overview
8.6.2. Other End Users Market Forecast and Analysis
9. LIVE ATTENUATED VACCINES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Live Attenuated Vaccines Market Overview
9.1.2 North America Live Attenuated Vaccines Market Forecasts and Analysis
9.1.3 North America Live Attenuated Vaccines Market Forecasts and Analysis - By Type
9.1.4 North America Live Attenuated Vaccines Market Forecasts and Analysis - By End User
9.1.5 North America Live Attenuated Vaccines Market Forecasts and Analysis - By Countries
9.1.5.1 United States Live Attenuated Vaccines Market
9.1.5.1.1 United States Live Attenuated Vaccines Market by Type
9.1.5.1.2 United States Live Attenuated Vaccines Market by End User
9.1.5.2 Canada Live Attenuated Vaccines Market
9.1.5.2.1 Canada Live Attenuated Vaccines Market by Type
9.1.5.2.2 Canada Live Attenuated Vaccines Market by End User
9.1.5.3 Mexico Live Attenuated Vaccines Market
9.1.5.3.1 Mexico Live Attenuated Vaccines Market by Type
9.1.5.3.2 Mexico Live Attenuated Vaccines Market by End User
9.2. EUROPE
9.2.1 Europe Live Attenuated Vaccines Market Overview
9.2.2 Europe Live Attenuated Vaccines Market Forecasts and Analysis
9.2.3 Europe Live Attenuated Vaccines Market Forecasts and Analysis - By Type
9.2.4 Europe Live Attenuated Vaccines Market Forecasts and Analysis - By End User
9.2.5 Europe Live Attenuated Vaccines Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Live Attenuated Vaccines Market
9.2.5.1.1 Germany Live Attenuated Vaccines Market by Type
9.2.5.1.2 Germany Live Attenuated Vaccines MARKET by End User
9.2.5.2 France Live Attenuated Vaccines Market
9.2.5.2.1 France Live Attenuated Vaccines Market by Type
9.2.5.2.2 France Live Attenuated Vaccines Market by End User
9.2.5.3 Italy Live Attenuated Vaccines Market
9.2.5.3.1 Italy Live Attenuated Vaccines Market by Type
9.2.5.3.2 Italy Live Attenuated Vaccines Market by End User
9.2.5.4 Spain Live Attenuated Vaccines Market
9.2.5.4.1 Spain Live Attenuated Vaccines Market by Type
9.2.5.4.2 Spain Live Attenuated Vaccines Market by End User
9.2.5.5 United Kingdom Live Attenuated Vaccines Market
9.2.5.5.1 United Kingdom Live Attenuated Vaccines Market by Type
9.2.5.5.2 United Kingdom Live Attenuated Vaccines Market by End User
9.2.5.6 Rest of Europe Live Attenuated Vaccines Market
9.2.5.6.1 Rest of Europe Live Attenuated Vaccines Market by Type
9.2.5.6.2 Rest of Europe Live Attenuated Vaccines Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Live Attenuated Vaccines Market Overview
9.3.2 Asia-Pacific Live Attenuated Vaccines Market Forecasts and Analysis
9.3.3 Asia-Pacific Live Attenuated Vaccines Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Live Attenuated Vaccines Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Live Attenuated Vaccines Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Live Attenuated Vaccines Market
9.3.5.1.1 Australia Live Attenuated Vaccines Market by Type
9.3.5.1.2 Australia Live Attenuated Vaccines Market by End User
9.3.5.2 China Live Attenuated Vaccines Market
9.3.5.2.1 China Live Attenuated Vaccines Market by Type
9.3.5.2.2 China Live Attenuated Vaccines Market by End User
9.3.5.3 India Live Attenuated Vaccines Market
9.3.5.3.1 India Live Attenuated Vaccines Market by Type
9.3.5.3.2 India Live Attenuated Vaccines Market by End User
9.3.5.4 Japan Live Attenuated Vaccines Market
9.3.5.4.1 Japan Live Attenuated Vaccines Market by Type
9.3.5.4.2 Japan Live Attenuated Vaccines Market By End User
9.3.5.5 South Korea Live Attenuated Vaccines Market
9.3.5.5.1 South Korea Live Attenuated Vaccines Market by Type
9.3.5.5.2 South Korea Live Attenuated Vaccines Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Live Attenuated Vaccines Market Overview
9.4.2 Middle East and Africa Live Attenuated Vaccines Market Forecasts and Analysis
9.4.3 Middle East and Africa Live Attenuated Vaccines Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Live Attenuated Vaccines Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Live Attenuated Vaccines Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Live Attenuated Vaccines Market
9.4.5.1.1 South Africa Live Attenuated Vaccines Market by Type
9.4.5.1.2 South Africa Live Attenuated Vaccines Market by End User
9.4.5.2 Saudi Arabia Live Attenuated Vaccines Market
9.4.5.2.1 Saudi Arabia Live Attenuated Vaccines Market by Type
9.4.5.2.2 Saudi Arabia Live Attenuated Vaccines Market by End User
9.4.5.3 U.A.E Live Attenuated Vaccines Market
9.4.5.3.1 U.A.E Live Attenuated Vaccines Market by Type
9.4.5.3.2 U.A.E Live Attenuated Vaccines Market by End User
9.4.5.4 Rest of Middle East and Africa Live Attenuated Vaccines Market
9.4.5.4.1 Rest of Middle East and Africa Live Attenuated Vaccines Market by Type
9.4.5.4.2 Rest of Middle East and Africa Live Attenuated Vaccines Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Live Attenuated Vaccines Market Overview
9.5.2 South and Central America live attenuated vaccines market forecasts and Analysis
9.5.3 South and Central America Live Attenuated Vaccines Market Forecasts and Analysis - By Type
9.5.4 South and Central America Live Attenuated Vaccines Market Forecasts and Analysis - By End User
9.5.5 South and Central America Live Attenuated Vaccines Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Live Attenuated Vaccines Market
9.5.5.1.1 Brazil Live Attenuated Vaccines Market by Type
9.5.5.1.2 Brazil Live Attenuated Vaccines Market By End User
9.5.5.2 Argentina Live Attenuated Vaccines Market
9.5.5.2.1 Argentina Live Attenuated Vaccines Market by Type
9.5.5.2.2 Argentina Live Attenuated Vaccines Market by End User
9.5.5.3 Rest of South and Central America Live Attenuated Vaccines Market
9.5.5.3.1 Rest of South and Central America Live Attenuated Vaccines Market by Type
9.5.5.3.2 Rest of South and Central America Live Attenuated Vaccines Market by End User
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. LIVE ATTENUATED VACCINES MARKET, KEY COMPANY PROFILES
11.1. EMERGENT BIOSOLUTIONS INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. GLAXOSMITHKLINE PLC
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. BIODIEM
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments

11.4. ASTRAZENECA
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. MERCK AND CO., INC.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. PFIZER INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. SANOFI
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. SERUM INSTITUTE OF INDIA PVT. LTD.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. CSL LIMITED
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. VIVALDI BIOSCIENCES INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Emergent BioSolutions Inc.
2. GlaxoSmithKline plc
3. BioDiem
4. AstraZeneca
5. Merck & Co., Inc.
6. Pfizer Inc.
7. Sanofi
8. Serum institute of India Pvt. Ltd.
9. CSL Limited
10. Vivaldi Biosciences Inc.